STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Reported by STAT News · all stories from statnews.com
Editorial digest
Epic Systems is reportedly under scrutiny from both federal and state investigators regarding its alleged anticompetitive business practices and the use of non-disclosure agreements.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Reputable trade press8/20/2026
FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
The FDA is considering 'competency-based' evaluations for generative AI medical devices.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Reputable trade press8/20/2026
FDA-cleared medical AI rarely tested for real-world benefits - News-Medical
FDA-cleared medical AI often lacks real-world benefit testing.
- Official source8/19/2026
Most AI medical devices cleared for use were not tested on patient outcomes - EurekAlert!
Many AI medical devices approved lacked patient outcome testing.
- Reputable trade press8/19/2026
Most AI medical devices cleared for use were not tested on patient outcomes - Medical Xpress
Most cleared AI medical devices lacked patient outcome testing.
